Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 17)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for CMED: the economy's impact on CMED's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25  View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25  View Abstract
4-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25  View Abstract
27-Dec-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25  View Abstract
30-Mar-09Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
30-Mar-09PriceTarget Research, Inc.N/AChina Med Technolgs has a current Overall Rating of B (Positive).7$25  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for MEDICAL SUPPLIES18$49  View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CMED13$25  View Abstract
Next 7
Brokerage Reports (Showing 1 to 2 of 2)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
20-Mar-09Brean Murray & Co., Inc.Hao HongFortnightly Chinese Takeaway: The China Syndrome6$30  View Abstract
20-Mar-09Brean Murray & Co., Inc.Eric M. Beder, Hao Hong, Jose HarescoMorning Insight (AMMD, JCG, SHFL, Fortnightly Chinese Takeaway)7$30  View Abstract
Independent Reports (Showing 1 to 10 of 15)
Release
Date [down]		 Contributor Author Title Pages Price More Info
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for CMED: the economy's impact on CMED's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25View Abstract
4-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25View Abstract
27-Dec-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: CHINA MEDICAL TECHNOLGS -ADR5$25View Abstract
30-Mar-09Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
30-Mar-09PriceTarget Research, Inc.N/AChina Med Technolgs has a current Overall Rating of B (Positive).7$25View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for MEDICAL SUPPLIES18$49View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for CMED13$25View Abstract
Next 5

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.